Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.
暂无分享,去创建一个
D. Burkhoff | D. Mancini | M. Maurer | P. Williams | Stephen Helmke | H. Rosenblum | Sergio Teruya | Margaret Jones | S. Helmke | S. Teruya